A Form 4 filing for Debbra L. Schoneman was submitted on November 3, 2026. It reports a sale on November 2. Form 4 is an SEC report of insider stock trades and other ownership changes.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-02 |
| Date of Latest Transaction | 2026-11-02 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 39,708 |
| Price | $67.38 |
| Total Transaction Value | $2,675,525.04 |
| Insider | |
| Ticker Symbol | PIPR |
| Company | PIPER SANDLER COMPANIES |
| Insider Name | Schoneman Debbra L. |
| Insider Title | President |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 11,752 |
| Position Size Change | 77.16% |
| Filing | |
| Filing Date | 2026-11-03 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of PIPR shares, reported with transaction code S. It may be tied to an exercise or conversion. An exercise means using a right to buy or receive shares. A conversion exchanges one type of investment for another.
What was the average price of the transaction?
The reported average price was $67.38 per share for the 39,708 shares sold.
How did this transaction affect the insider's holdings?
Debbra L. Schoneman sold 39,708 shares and reported owning 11,752 shares afterward. Based on that reported balance, the sale represented 77.16% of the shares held before the sale.
What's the total transaction value?
The total reported sale value was $2,675,525.04 for one transaction.
Are there any special circumstances around this transaction?
Yes. The sale appears linked to shares received through a code M exercise or conversion. The link is based on matching share counts in the same filing. Details of the related acquisition and the filing footnotes are unavailable here.
Matching share counts alone do not confirm that both steps involved the same date, account, or exact shares. The match also does not establish that the sale covered taxes, explain how any exercise was paid for, or show why the shares were sold.
For research purposes only; not investment advice.